Stemcells: the new frontier of medicine at SSCB

Stemcell is the new frontier of medicine and genetics. Indeed, stemcells are "non-specialised" cells that have yet to be divided to become fully differentiated cells. For this specific characteristic, the stemcells have the potential to renew themselves and so can be used in human therapy to repair damaged organs and tissues.

SSCB, Swiss Stem Cells Bank, is the new stemcells bank that offers the possibility to store the stemcells present in the umbilical cord blood for future use. The stemcells coming from the umbilical cord blood, being autologous, can be used to cure the newborn in the future and maybe save his or her life.

SSCB, thanks to the collaboration with Molecular diagnostics laboratory and the Cardiocentro Ticino in Lugano, is in the frontline of research and development of new technologies regarding both the cryconservation of the stemcells and their use in human therapy. Stemcell transplant today is used to cure, in particular, patients suffering from leukaemia and lymphomas but stemcells can be used also in the treatment of myocardial infarction. Stemcell transplant is also a valid alternative to the difficult bone marrow transplant. Current research is focussing on other potential uses of stemcell technology in the treatment of other kind of diseases such as spinal cord injuries subsequent to a trauma, neurodegenerative diseases (i.e. Parkinson's disease and Alzheimer disease), metabolic diseases (i.e. diabetes)or bones reconstruction.

SSCB, Swiss Stem Cells Bank, offers an innovative and easy banking service for stemcells taken from the umbilical cord blood. It is not necessary to reside or deliver in Switzerland to take advantage of SSBC's services.

Learn more about the Swiss Stem Cells Bank!